| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/15/2004 | WO2004039426A8 Transdermal delivery system for water insoluble drugs |
| 07/15/2004 | WO2004037190A3 Modified release compositions of milnacipran |
| 07/15/2004 | WO2004030650A3 Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
| 07/15/2004 | WO2004019977A3 Improved bacterial outer membrane vesicles |
| 07/15/2004 | WO2004019911A3 Buccal, polar or non-polar spray or capsule containing drugs for treating endocrine disorders |
| 07/15/2004 | WO2004019853A3 Dosage forms having reduced moisture transmission |
| 07/15/2004 | WO2003101404A3 Preparations for topical skin use and treatment |
| 07/15/2004 | WO2003101357A9 Transmucosal delivery of cannabinoids |
| 07/15/2004 | WO2003088894A3 A multi component controlled release system for anhydrous cosmetic compositions |
| 07/15/2004 | WO2003087108A3 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003087040A3 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003080079B1 Use of sulfoalkyl ether cyclodextrin as a preservative |
| 07/15/2004 | WO2003078579A3 Compositions and methods for treating emphysema |
| 07/15/2004 | WO2003075852A3 Antibiotic composition |
| 07/15/2004 | WO2003047513A3 Method for treating ocular hypertension |
| 07/15/2004 | WO2003018751A3 Apparatus and method for electroporation of biological samples |
| 07/15/2004 | US20040138648 Drug delivery system for implantable medical device |
| 07/15/2004 | US20040138647 Cycle mode providing redundant back-up to ensure termination of treatment therapy in a medical device system |
| 07/15/2004 | US20040138646 Device for administering a substance transdermally |
| 07/15/2004 | US20040138630 Aqueous ophthalmic spray and method for delivery of artificial tears to the ocular surface |
| 07/15/2004 | US20040138610 Increased depth and uniformity of transdermal penetration; microprojection array and impact applicator tip |
| 07/15/2004 | US20040138603 Ultra thin film transdermal/dermal or transmucosal/mucosal delivery system |
| 07/15/2004 | US20040138415 Helicobacter proteins, nucleic acids and uses thereof |
| 07/15/2004 | US20040138411 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media |
| 07/15/2004 | US20040138329 Gels for encapsulation of biological materials |
| 07/15/2004 | US20040138306 Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 07/15/2004 | US20040138299 Dispersion of bicalutamide for prostate cancer treatment |
| 07/15/2004 | US20040138295 Solid pharmaceutical formulation containing lovastatin and simvastatin respectively, and its preparation |
| 07/15/2004 | US20040138293 Pharmaceutical composition made of cannabis extracts |
| 07/15/2004 | US20040138290 Atorvastatin calcium in a pharmaceutical form composition thereof and pharmaceutical formulation comprising atorvastatin calcium |
| 07/15/2004 | US20040138263 Pharmaceutical compositions and dosage forms of thalidomide |
| 07/15/2004 | US20040138237 Novel injectable depot formulations |
| 07/15/2004 | US20040138231 Pharmaceutical composition which comprise a solid dispersion of a hydroxypropyl-methylcellulose phthalate polymer |
| 07/15/2004 | US20040138180 Bisphosphonate composition and process for the preparation thereof |
| 07/15/2004 | US20040138169 Competitive binding with enzyme involved in metabolism of homoocysteine; permeability of erythrocyte membrane; enzyme inhibitor |
| 07/15/2004 | US20040138167 Administering a nucleic acid; prevention infections, Dna damage, tumors,skin disorders |
| 07/15/2004 | US20040138156 Therapeutic regulation of deoxyribonuclease-1-like-3 activity |
| 07/15/2004 | US20040138149 slurrying; precipitation; for treatment of bacterial infections |
| 07/15/2004 | US20040138132 Membrane translocating peptide drug delivery system |
| 07/15/2004 | US20040138109 Viricides such as ciluprevir in solutions of polyethylene glycol, ethanol, propylene glycol, water and/or mixtures, used for prophylaxis or prevention of hepatitis C virus (HCV) infections |
| 07/15/2004 | US20040138105 Modulators of polysaccharides and uses thereof |
| 07/15/2004 | US20040138101 Prophylaxis of bone disorders comprising administering insulin and derivatives, and optionally in combination with peptide growth factors, metabolic antagonist, osteoprotegerins, synovial or antiinflammatory agents, in sustained release form |
| 07/15/2004 | US20040138098 Pharmaceutical compositions including low dosages of desmopressin |
| 07/15/2004 | US20040138095 Colloidal suspension of nanoparticles based on an amphiphilic copolymer |
| 07/15/2004 | US20040138074 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 07/15/2004 | US20040137613 Biological scaffolding material |
| 07/15/2004 | US20040137179 Synechia inhibitory material |
| 07/15/2004 | US20040137174 Gastric juice-resistant device for releasing mucoadhesive active substance excipients, and method for producing this gastric juice-resistant device |
| 07/15/2004 | US20040137156 for sustained release; compressed tablets/capsules |
| 07/15/2004 | US20040137140 Pharmaceutical dispensing apparatus and method |
| 07/15/2004 | US20040137088 Improved, color-stable extract of St John's wort having reduced or absent amounts of chorophyll and proanthocyanidins; gels for skin disorders and mucous membrane irritations; acne, atopic dermatitis; neurodermatitis; bactericides; viricides |
| 07/15/2004 | US20040137079 A stable aqueous solution of hyaluronic acid, a stabilized oxy-chloro complex, e.g., chlorine dioxide, a boric acid/borate buffer to maintain a pH of 6-9 and no more than 0.0075% hydrogen peroxide; storage; conditioning; increased comfort; dry eye |
| 07/15/2004 | US20040137078 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 07/15/2004 | US20040137071 Nanocapsule encapsulation system and method |
| 07/15/2004 | US20040137070 Drug particles from freezing onto a surface |
| 07/15/2004 | US20040137069 Pirenzepine ophthalmic gel |
| 07/15/2004 | US20040137068 A sterile formulation of a biocompatible chelating agent, a permeability promoter, Advanced Glycation Endproducts (AGE) selected from breakers, formation inhibitors, and glycation inhibitors and a carrier; vision defects; inserts |
| 07/15/2004 | US20040137063 allows for accessibility of the biologically active substances to the host organism while remaining inaccessible to the antibodies and immune system cells of the host; surface treated polycarbonate porous membrane coated with hydrophilic polymer |
| 07/15/2004 | US20040137062 Chronotherapy tablet and methods related thereto |
| 07/15/2004 | US20040137061 Functional grain-containing preparations quickly disintegrated in the oral cavity |
| 07/15/2004 | US20040137060 monodispersed microspheres; made by transforming to liquiform in the absence of dissolving medium, to liquiflash conditions, said liquid having substantially unimpeded internal flow, and imparting shear force to form particles, coating particles |
| 07/15/2004 | US20040137059 Biodegradable ocular implant |
| 07/15/2004 | US20040137058 Effervescent bisphosphonate formulation |
| 07/15/2004 | US20040137057 forming compressed dosage forms by applying suction to a die cavity to cause powder to flow into said die cavity, said suction being applied through a filter; dosage forms made without water soluble polymer binder |
| 07/15/2004 | US20040137056 prepared without the addition of binder; instead, the drug itself acts as a binder; dosage forms; fosamax for example |
| 07/15/2004 | US20040137055 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 07/15/2004 | US20040137054 separated by a physiologically acceptable inert material such as microcrystalline cellulose and/or pregelatinised starch; storage stability; combination dosage for better patient compliance |
| 07/15/2004 | US20040137053 Method for making water soluble a poorly water soluble antiseptic |
| 07/15/2004 | US20040137052 mixture of a drug having anti-allergy, anti-histamine, anti-inflammatory, anti-PAF (platelet-aggregating factor) or eosinophile chemotaxis inhibiting activity and an acid; dosage form; excellent in the digestive tract absorbability and stability |
| 07/15/2004 | US20040137051 Wound healing compositions and methods of use |
| 07/15/2004 | US20040137049 Amphotericin b aqueous composition |
| 07/15/2004 | US20040137048 Thermolabile liposome with controlled release temperature |
| 07/15/2004 | US20040137046 such as selegiline and/or the use of protonated forms of various drugs; an adhesive, the drug in protonated form, a nonaqueous solvent that dissolves said drug in either protonated or unprotonated form, and a biocompatible deprotonating agent |
| 07/15/2004 | US20040137045 Hot-melt TTS for administering Rotigotine |
| 07/15/2004 | US20040137044 Transdermal delivery system for dried particulate or lyophilized medications |
| 07/15/2004 | US20040137043 microcrystalline cellulose and carrageenan and a strengthening polymer, and/or a plasticizer; does not retard the release of active ingredients when placed or ingested into an aqueous medium; dosage forms; coated candy, foods, agricultural chemical |
| 07/15/2004 | US20040137041 Water-soluble natural film and its preparing method |
| 07/15/2004 | US20040137040 Orally administered agent and an orally administered agent/supporting substrate complex |
| 07/15/2004 | US20040137039 molecules such as bioactive agents are selectively and reversibly released from a layered polymer film that modulates its electrostatic charged state in response to changes in the pH in the environment of the film; drug delivery |
| 07/15/2004 | US20040137037 gel comprising a protein that does not coagulate at pH 3 to 4; calcium; acid; carbohydrate; fat; emulsifier; agar; and water; food; nutraceutical; increasing blood (plasma) volume for improved excercise endurance, heat tolerance |
| 07/15/2004 | US20040137034 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 07/15/2004 | US20040137027 dissolving a water-soluble partially hydrolyzed polyvinyl alcohol in water to form a solution, adding flavors and fragrances and then a solubilizing additive to prevent the evaporation and dissolution of flavores from the solution, coating, drying |
| 07/15/2004 | US20040137014 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis |
| 07/15/2004 | US20040137006 an anti-allergic agent, comprising a molecule having at least a first segment competent for importation of the molecule into mast cells, and a second segment for having an anti-allergic effect within the mast cells |
| 07/15/2004 | US20040137004 immunologically-active protein of immunogenic formulation applied to the pressure-sensitive adhesive layer opposite the backing layer and/or incorporated in pressure-sensitive adhesive layer such that the protein is in contact with adhesive |
| 07/15/2004 | US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 07/15/2004 | US20040136971 Implantation of encapsulated biological materials for treating diseases |
| 07/15/2004 | US20040136970 negatively charged carrier, such as hyaluronic acid, are administered to a synovial joint, the stimulatory effects of the FGF18 are enhanced |
| 07/15/2004 | US20040136961 comprising a water-based core solution which itself comprises polyanionic polymers and an adenoviral polynucleotide construct or a drug and a water-based corona solution surrounding the core solution comprising at least one cation |
| 07/15/2004 | US20040136925 mixture of hyaluronic acids of various molecular weight, properly added with suitable diluents, which demonstrated to possess an interesting antiflogistic, antioxidant and tissue repair activity |
| 07/15/2004 | US20040136924 Oral care compositions and methods |
| 07/15/2004 | US20040136923 Edible film for relief of cough or symptoms associated with pharyngitis |
| 07/15/2004 | US20040136922 film delivers at least one oral care agent, such as antimicrobial agents and salivary stimulants |
| 07/15/2004 | US20040136920 aerosol formulation which comprises particulate salbutamol or a physiologically acceptable salt or solvate thereof and 1,1,1,2-tetrafluoroethane as propellant, which formulation is substantially free of surfactant |
| 07/15/2004 | US20040136919 Tiotropium containing powder formulation for inhalation |
| 07/15/2004 | US20040136915 Buccal, polar and non-polar spray containing atropine |
| 07/15/2004 | US20040136914 Buccal, polar and non-polar spray containing ondansetron |
| 07/15/2004 | US20040136913 Buccal, polar and non-polar spray containing sumatriptan |
| 07/15/2004 | US20040136905 Magnetically guided particles for radiative therapies |
| 07/15/2004 | US20040136904 Dry powder compositions comprising labelled particles for inhalation |